This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cigna (CI) Q1 Earnings Beat Mark, Rise Y/Y on Revenue Gains
by Zacks Equity Research
Cigna's (CI) Q1 results reflect higher pharmacy revenues, and fees and other income.
Community Health (CYH) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Community Health's (CYH) first-quarter results reflect decline in operating and interest expenses, partly offset by weaker admissions.
Humana's (HUM) Q1 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) Q1 earnings gain from better revenues and a solid contribution by its Retail segment.
5 Spectacularly Perfect Earnings Charts
by Tracey Ryniec
These 5 companies haven't missed on earnings in 5 years. Amazing.
Humana (HUM) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Humana's (HUM) first-quarter results are likely to reflect better revenues and strong Medicaid and Medicare businesses, partly offset by Specialty business and high costs.
UnitedHealth (UNH) to Help Eligible Medicaid Members in Ohio
by Zacks Equity Research
UnitedHealth (UNH) intends to improve health outcomes of eligible Medicaid members in Ohio where it already boasts a strong presence.
Molina (MOH) to Aid Medicaid Members in Ohio Via Contract Wins
by Zacks Equity Research
Molina (MOH) is selected by the Ohio Department of Medicaid to serve beneficiaries across the state.
Humana (HUM) to Support Eligible Medicaid Members in Ohio
by Zacks Equity Research
Humana (HUM) to improve health outcomes of Medicaid members in Ohio through contract wins.
Here's Why You Should Retain Cigna (CI) in Your Portfolio
by Zacks Equity Research
Cigna (CI) is set to benefit from growing revenues, well-performing growth platforms and robust capital position.
Humana (HUM) is Overbought: Is A Drop Coming?
by Zacks Equity Research
Humana (HUM) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Here's Why You Should Stay Away From Anthem (ANTM) Right Now
by Zacks Equity Research
Anthem's (ANTM) weak balance sheet and steep expenses will likely keep the stock stressed.
Acadia Healthcare (ACHC) Forms JV For Catering to Fort Wayne
by Zacks Equity Research
Acadia Healthcare (ACHC) forms alliance with Lutheran Health Network aimed to offer improved behavioral health services across Fort Wayne and neighboring counties.
Humana (HUM) Extends Ties for Automating Prior Authorizations
by Zacks Equity Research
Humana (HUM) expands partnership with Epic in a bid to offer electronic prior authorizations, member insights and other capabilities for patients and providers.
Anthem (ANTM) to Buy myNEXUS to Boost Homehealth Business
by Zacks Equity Research
Anthem (ANTM) to purchase at-home provider, benefits coordinator, myNEXUS, to provide better in-home care.
Humana (HUM), Inovalon Expands Ties for Vaccine Adherence Efforts
by Zacks Equity Research
Humana (HUM) extends collaboration with Inovalon, which highlights the company's focus on vaccine adherence for helping its health plan members.
UnitedHealthcare (UNH) Expands Virtual Care to Hearing Aids
by Zacks Equity Research
UnitedHealthcare's (UNH) new virtual care model Right2You aims to provide its members with an online service for custom-programed hearing aids.
Centene (CNC) vs. Humana (HUM): Which is Better-Positioned?
by Zacks Equity Research
Centene (CNC) and Humana (HUM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable based on fundamentals.
Humana (HUM) Puts Senior-Focused Centers Under CenterWell Brand
by Zacks Equity Research
Humana (HUM) unveils the CenterWell brand, which will bring together the company's senior-focused primary care centers in a bid to offer personalized health care plans for senior patients.
UnitedHealth (UNH) Invests in Technology to Lead the Industry
by Zacks Equity Research
The breakout of COVID-19 fuels the use of technology in the healthcare space and UnitedHealth (UNH) is promptly acting on this to ramp up its technological innovations.
The Zacks Analyst Blog Highlights: UnitedHealth Group, Pfizer, International Business Machines, Humana and Exelon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth Group, Pfizer, International Business Machines, Humana and Exelon
Top Analyst Reports for UnitedHealth, Pfizer & IBM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Pfizer (PFE), and International Business Machines (IBM).
Humana (HUM) Up 0.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) Unit Expands to Meet Senior-Focused Health Needs
by Zacks Equity Research
Humana's (HUM) subsidiary Conviva acquires a primary care physician network in South Florida for boosting healthcare services offered to seniors across the region.
Cigna (CI) Set to Expand in Telehealth Via MDLIVE Buyout
by Zacks Equity Research
Cigna (CI) is set to buy MDLIVE, a provider of telehealth services, to gain share in the growing market.
Magellan's (MGLN) Q4 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) results reflect a decline in earnings and revenues due to lower contribution from Healthcare and Pharmacy Management units.